Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial (Q38871183)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2010
edit
Language Label Description Also known as
English
Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial
scientific article published on January 2010

    Statements

    Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial (English)
    Wendy B Snowden
    Florence Odongo
    Kimberly Adkison
    David Burger
    Adeodata Kekitiinwa
    1 January 2010
    1115-1124

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit